Evidence map›Paper›PMID 24298446›Full record

ArticleNeuroImage. Clinical2014

Prefrontal activation during inhibitory control measured by near-infrared spectroscopy for differentiating between autism spectrum disorders and attention deficit hyperactivity disorder in adults.

Ayaka Ishii-Takahashi, Ryu Takizawa, Yukika Nishimura, Yuki Kawakubo, Hitoshi Kuwabara, Junko Matsubayashi, Kasumi Hamada, Shiho Okuhata, Noriaki Yahata, Takashi Igarashi and 5 more

Open access · goldAbstract read
In one paragraph

Article in NeuroImage. Clinical, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Neuroimaging-Aided Prediction of the Effect of Methylphenidate in Children with Attention-Deficit Hyperactivity Disorder: A Randomized Controlled Trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
    Trial
  5. Cognitive Aging Patterns in Autism: Parallel, Accelerated, or Safeguarded?Journal of autism and developmental disorders · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Applications of Functional Near-Infrared Spectroscopy (fNIRS) Neuroimaging During Rehabilitation Following Stroke: A Review.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Review
  13. Article
  14. Article
  15. Toward Precision Medicine in ADHD.Frontiers in behavioral neuroscience · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Ayaka Ishii-TakahashiDepartment of Neuropsychiatry Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Ryu Takizawa
Yukika Nishimura
Yuki Kawakubo
Hitoshi Kuwabara
Junko Matsubayashi
Kasumi Hamada
Shiho Okuhata
Noriaki Yahata
Takashi Igarashi
Shingo Kawasaki
Hidenori Yamasue
Nobumasa Kato
Kiyoto Kasai
Yukiko Kano
The University of Tokyo · JPHitachi (Japan) · JPKyoto University · JPShowa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The differential diagnosis of autism spectrum disorders (ASDs) and attention deficit hyperactivity disorder (ADHD) based solely on symptomatic and behavioral assessments can be difficult, even for experts. Thus, the development of a neuroimaging marker that differentiates ASDs from ADHD would be an important contribution to this field. We assessed the differences in prefrontal activation between adults with ASDs and ADHD using an entirely non-invasive and portable neuroimaging tool, near-infrared spectroscopy. This study included 21 drug-naïve adults with ASDs, 19 drug-naïve adults with ADHD, and 21 healthy subjects matched for age, sex, and IQ. Oxygenated hemoglobin concentration changes in the prefrontal cortex were assessed during a stop signal task and a verbal fluency task. During the stop signal task, compared to the control group, the ASDs group exhibited lower activation in a broad prefrontal area, whereas the ADHD group showed underactivation of the right premotor area, right presupplementary motor area, and bilateral dorsolateral prefrontal cortices. Significant differences were observed in the left ventrolateral prefrontal cortex between the ASDs and ADHD groups during the stop signal task. The leave-one-out cross-validation method using mean oxygenated hemoglobin changes yielded a classification accuracy of 81.4% during inhibitory control. These results were task specific, as the brain activation pattern observed during the verbal fluency task did not differentiate the ASDs and ADHD groups significantly. This study therefore provides evidence of a difference in left ventrolateral prefrontal activation during inhibitory control between adults with ASDs and ADHD. Thus, near-infrared spectroscopy may be useful as an auxiliary tool for the differential diagnosis of such developmental disorders.

Indexed as

Inhibition, PsychologicalSpectroscopy, Near-InfraredAdultAnalysis of VarianceAttention Deficit Disorder with HyperactivityCase-Control StudiesChild Development Disorders, PervasiveChoice BehaviorFemaleHemoglobinsHumansMaleNeuropsychological TestsPrefrontal CortexPsychiatric Status Rating ScalesReaction TimeHemoglobinsAttention deficit hyperactivity disorderAutism spectrum disordersInhibitory controlNear-infrared spectroscopyStop signal task

Identifiers

PMID24298446
PMCPMC3842411
OpenAlexW1971154916

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.